Interaction of ketamine and halothane in rats

Area of Science:

• Pharmacology
• Anesthesiology
• Neuroscience

Background:

• Ketamine is an anesthetic agent with a short duration of action.
• Its N-demethylated metabolite (metabolite I) is also pharmacologically active.
• Interactions between ketamine, its metabolite, and other anesthetics like halothane are not fully understood.

Purpose of the Study:

• To evaluate the interaction between intramuscularly injected ketamine and its metabolite I with halothane in rats.
• To determine the effect of ketamine and metabolite I on halothane anesthetic requirement (MAC).
• To assess the impact of halothane on ketamine's pharmacokinetic profile.

Main Methods:

• Rats were administered varying doses of ketamine or metabolite I alone.
• Halothane anesthetic requirement (MAC) was measured after ketamine or metabolite I administration.
• Brain and plasma levels of ketamine and metabolite I were quantified.
• Ketamine's half-life was compared in the presence and absence of halothane.

Main Results:

• Ketamine or metabolite I alone produced hypnosis for less than 10 minutes.
• Ketamine (50 mg/kg) significantly reduced MAC in a dose-dependent manner (up to 56% at 1-2 hours and 14% at 5-6 hours).
• Reduced MAC correlated with brain drug levels, suggesting a ketamine:metabolite I potency ratio of 3:1.
• Halothane prolonged the half-life of ketamine in plasma and brain.

Conclusions:

• Ketamine is not a short-acting drug, especially when co-administered with halothane.
• Concomitant use of ketamine and halothane is expected to prolong the central nervous system effects of ketamine.
• This interaction has implications for anesthetic management and drug duration monitoring.